Evoke Wealth’s Omnicell OMCL Stock Holding History

Evoke Wealth’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,855	Closed	-$1.47M	–	890
2022 Q3	$1.47M	Buy	16,855 +16,216	+2,538%	+$1.7M	0.06%	120
2022 Q2	$73K	Buy	+639	New	+$73.3K	﹤0.01%	451
2020 Q1	–	Sell	-166	Closed	-$13.6K	–	1290
2019 Q4	$13.6K	Hold	166	–	–	﹤0.01%	674
2019 Q3	$12K	Buy	+166	New	+$12.2K	﹤0.01%	782

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Evoke Wealth's OMCL Position: Q4 2022 in Review

Evoke Wealth sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 16,855 shares — an estimated $1.47M sold.

Evoke Wealth first reported a position in OMCL in Q3 2019 and held it in 4 quarters. The position peaked at $1.47M in Q3 2022. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

Evoke Wealth reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
Evoke Wealth sold 16,855 Omnicell shares in Q4 2022, an estimated $1.47M.
Evoke Wealth first reported a position in Omnicell in Q3 2019 and held it in 4 quarters.
Evoke Wealth's Omnicell position peaked at $1.47M in Q3 2022.
329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.